| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | HLA pharmacogenetic markers of drug hypersensitivity in a Thai population | Nakkam, N Kanjanawart, S. Kongpan, T. Tassaneeyakul, W. |
2018 | ||||
| 2. | Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. | Nakkam, N Konyoung, P Kanjanawart, S Saksit, N Kongpan, T Khaeso, K Khunarkornsiri, U Dornsena, A Tassaneeyakul, W Tassaneeyakul, W |
2018 | ||||
| 3. | Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients. | Kanyarat Khaeso Nontaya Nakkam Patcharee Komwilaisak Piyathida Wongmast Su-on Chainansamit Areerat Dornsena Sirimas Kanjanawart Suda Vannaprasaht Wichittra Tassaneeyakul |
2021 | ||||
| 4. | NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine | Khaeso, K Komvilaisak, P Chainansamit, SO Nakkam, N Suwannaying, K Kuwatjanakul, P Hikino, K Dornsena, A Kanjanawart, S Laoaroon, N Vannaprasaht, S Taketani, T Tassaneeyakul, W |
2022 | Count | 2 | 3 | 1 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
| 1. | HLA pharmacogenetic markers of drug hypersensitivity in a Thai population | Nakkam, N Kanjanawart, S. Kongpan, T. Tassaneeyakul, W. |
2018 |
Frontiers in Genetics AUG (9), pp. |
||||||||
| 2. | NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine | Khaeso, K. Komvilaisak, P. Chainansamit, S.O. Nakkam, N. Kanjanawart, S. Vannaprasaht, S. Tassaneeyakul, W. |
2022 |
Drug Metabolism and Pharmacokinetics (43), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. | Nakkam, N Konyoung, P Kanjanawart, S Saksit, N Kongpan, T Khaeso, K Khunarkornsiri, U Dornsena, A Tassaneeyakul, W Tassaneeyakul, W |
2018 |
Frontiers in genetics (9), pp. 277 |
|
| 2. | Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients. | Khaeso, K Nakkam, N Komwilaisak, P Wongmast, P Chainansamit, SO Dornsena, A Kanjanawart, S Vannaprasaht, S Tassaneeyakul, W |
2021 |
Journal of pediatric genetics 1 (10), pp. 29-34 |
|
| 3. | NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine. | Khaeso, K Komvilaisak, P Chainansamit, SO Nakkam, N Suwannaying, K Kuwatjanakul, P Hikino, K Dornsena, A Kanjanawart, S Laoaroon, N Vannaprasaht, S Taketani, T Tassaneeyakul, W |
2022 |
Drug metabolism and pharmacokinetics (43), pp. 100436 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
| 1. | Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients | Kanyarat Khaeso Nontaya Nakkam Patcharee Komwilaisak Piyathida Wongmast Su-on Chainansamit Areerat Dornsena Sirimas Kanjanawart Suda Vannaprasaht Wichittra Tassaneeyakul |
2021 |
JOURNAL OF PEDIATRIC GENETICS 1.0 (10.0), pp. 29.0-34.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|